CBD & Multiple Sclerosis: An Effective Remedy for Natural MS Treatment?
|
Time to read 6 min
Free delivery on orders over €59 🚚
|
Time to read 6 min
Multiple Sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system that affects the lives of millions worldwide. Symptoms range from muscle weakness and spasticity to chronic pain and fatigue.
Despite significant medical advances in MS therapy, many sufferers are looking for natural ways to alleviate their symptoms and improve their quality of life. Cannabidiol (CBD), a non-psychoactive compound from the cannabis plant, has emerged as a much-discussed candidate, attracting increasing attention from researchers and patients in recent years.
But how does CBD work in MS? Can it actually alleviate symptoms and make everyday life easier? In this article, we shed light on the scientific background, experiences of affected individuals, and the current state of research on CBD as an adjunct therapy for Multiple Sclerosis.
Table of Contents
Cannabidiol (CBD) can help improve the quality of life for MS patients by, for example, improving sleep quality, alleviating chronic pain, and counteracting muscle spasms.
The reason for the diverse effects of CBD in Multiple Sclerosis is not yet precisely understood, but interaction with the endocannabinoid system (ECS) is suspected.
CBD may even help to positively influence the course of the disease - however, research is still in its early stages here.
Research into Multiple Sclerosis has made significant progress in recent years, particularly in identifying genetic and immunological factors that influence the disease. Modern therapies aim to slow disease progression and reduce inflammatory relapses, while new approaches such as remyelination therapies and stem cell research offer hope for long-term cures.
Nevertheless, many questions remain unanswered, especially regarding individual prognosis and prevention. For many sufferers, the question also arises: How can I improve my own quality of life and cope better with my symptoms - and ideally without the side effects of conventional medications?
The focus is primarily on the possible alleviation of muscle spasms, the reduction of chronic pain, and an improvement in sleep, as these symptoms are often difficult to treat or require strong medications.
Our customers' opinions:
Recommended products
The study situation regarding the treatment of MS symptoms with CBD is mixed. While preclinical studies and some smaller clinical studies indicate potential benefits, there are still no sufficient, large-scale clinical studies.¹ However, CBD generally shows promising approaches as a complementary therapy in the treatment of MS symptoms such as spasticity and neuropathic pain. Some studies also report improvements in sleep quality and an overall higher quality of life in MS patients due to CBD intake.²
It is not yet fully clear what this comprehensive effect of CBD in Multiple Sclerosis is based on. However, it is suspected that interaction with the endocannabinoid system ( ECS ) plays a role.
In preclinical studies, CBD showed anti-inflammatory properties in animal models by reducing T-cell infiltrates in the spinal cord. This led to a delay in disease onset and slowed disease progression.³ However, clinical studies are still lacking to make truly reliable statements.
Fundamentally: Research into the effects of CBD in Multiple Sclerosis is still in its early stages, and the results are far from conclusive. However, there is agreement regarding the side effects of cannabidiol (CBD) intake: Compared to common MS medications and other products from the cannabis plant (e.g., THC), CBD has very few side effects and is well tolerated.
Even though CBD has very few side effects, undesirable effects can occur with its use. The most commonly reported side effects include diarrhea, fatigue, dizziness, lightheadedness, and dry mouth. A 2017 study by Iffland & Grotenhermen ⁴ cites diarrhea and fatigue as common side effects, but these are usually minor compared to other medications and quickly subside when the dose is reduced.
Additionally, CBD can lower blood pressure, which may cause dizziness in some individuals. This is a side effect that occurs particularly with higher doses. Furthermore, CBD can sometimes trigger headaches. Here too, the intensity is low, and the side effects disappear as soon as the dosage is reduced.
Certain groups of people, such as pregnant women, breastfeeding mothers, or individuals taking other medications, should generally be particularly cautious with CBD due to possible interactions. Interactions can influence or strengthen the effect of other medications, which can lead to further side effects.
We therefore recommend that you start with a low dosage and observe your individual reaction. Increase slowly and in consultation with your doctor until you achieve the desired effect.
Many people with MS already have to take a lot of medication and are accordingly cautious when it comes to using CBD. Main concerns relate to the side effects of MS, which we have already discussed above, but also the question of whether CBD, like other cannabis products (THC), is addictive or psychoactive.
Neither is the case. However, studies (1) suggest that cannabinoids like CBD and THC could affect the nervous system, potentially leading to cognitive impairment or neurological problems. Therefore, only take CBD for MS in consultation with a doctor to minimize risks and interactions with medications and to ensure the correct dosage.
The dosage of CBD for Multiple Sclerosis (MS) must be individually adjusted and depends on various factors such as body weight, metabolism, and the respective symptoms. We recommend starting with a CBD oil with a concentration of 15 % to 25 %. The daily dosage is usually between 20 and 80 mg (approximately 3 to 10 drops per day). Gradually adjust the dosage until you achieve the desired effect.
Many of our users take CBD in the evening to relieve typical MS symptoms such as sleep disorders, pain, or fatigue attacks. The combination with a lower concentration CBD product for daytime use can also help reduce spasticity during the day.
Important: Always consult your doctor before use and discuss the appropriate product and correct dosage - also to avoid interactions with medications.
CBD (Cannabidiol) can help alleviate symptoms of Multiple Sclerosis and significantly improve the quality of life of those affected. Regular intake can relieve symptoms such as spasticity (muscle spasms), chronic pain, sleep disturbances, and fatigue attacks. In contrast to conventional MS medications, CBD has significantly fewer side effects. Initial studies also suggest that CBD, through its anti-inflammatory properties, could influence the course of the disease, although large-scale clinical studies are still lacking to clearly confirm this effect.
The use of CBD for MS should always be done in consultation with a doctor to rule out interactions with other medications and individual risks. Overall, CBD is certainly not a miracle cure - but it can help many MS patients improve their quality of life as a complementary therapy.
Sources and Studies
¹ Inglet, S., Winter, B., Yost, S. E., Entringer, S., Lian, A., Biksacky, M., Pitt, R. D., & Mortensen, W. (2020). Clinical data for the use of cannabis-based treatments: A comprehensive review of the literature. Annals of Pharmacotherapy, 54(11), 1109–1143.
² de Fátima Dos Santos Sampaio, M., de Paiva, Y. B., Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2024). Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders. Basic & Clinical Pharmacology & Toxicology, 134(5), 574–601.
³ Jones, É., & Vlachou, S. (2020). A critical review of the role of the cannabinoid compounds Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment. Molecules, 25(21), 4930.
⁴ Iffland, K., & Grotenhermen, F. (2017). An update on safety and side effects of cannabidiol: A review of clinical data and relevant animal studies. Cannabis and Cannabinoid Research, 2(1), 139–154.